Regulation of Bcl-xL Expression by H2O2 in Cardiac Myocytes*,

Donna M. Valks, Timothy J. Kemp and Angela Clerk {ddagger}

From the National Heart and Lung Institute Division (Cardiac Medicine Section), Faculty of Medicine, Imperial College London, Flowers Building, Armstrong Road, London SW7 2AZ, United Kingdom

Received for publication, April 10, 2003 , and in revised form, April 23, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Oxidative stress promotes cardiac myocyte apoptosis through the mitochondrial death pathway. Since Bcl-2 family proteins are key regulators of apoptosis, we examined the effects of H2O2 on the expression of principal Bcl-2 family proteins (Bcl-2, Bcl-xL, Bax, Bad) in neonatal rat cardiac myocytes. Protein expression was assessed by immunoblotting. Bcl-2, Bax, and Bad were all down-regulated in myocytes exposed to 0.2 mM H2O2, a concentration that induces apoptosis. In contrast, although Bcl-xL levels initially declined, the protein was re-expressed from 4–6 h. Bcl-xL mRNA was up-regulated from 2 to 4 h in neonatal rat or mouse cardiac myocytes exposed to H2O2, consistent with the re-expression of protein. Four different untranslated first exons have been identified for the Bcl-x gene (exons 1, 1B, 1C, and 1D, where exon 1 is the most proximal and exon 1D the most distal to the coding region). All were detected in mouse or rat neonatal cardiac myocytes, but exon 1D was not expressed in adult mouse hearts. In neonatal mouse or rat cardiac myocytes, H2O2 induced the expression of exons 1B, 1C, and 1D, but not exon 1. These data demonstrate that the Bcl-x gene is selectively responsive to oxidative stress, and the response is mediated through distal promoter regions.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cardiac myocytes, the contractile cells of the heart, are terminally differentiated cells, which withdraw from the cell cycle in the perinatal period. Consequently, myocyte cell death, as occurs (for example) following ischemia and/or reperfusion, significantly affects cardiac function. One of the principal insults that may promote cardiac myocyte death is oxidative stress, and the levels of oxidative stress are increased in ischemic hearts (1, 2) with higher levels being produced following reperfusion (3). H2O2 (0.1–0.5 mM), as an example of oxidative stress, promotes cardiac myocyte apoptosis through the mitochondrial death pathway (4). However, lower concentrations are non-toxic and may have cytoprotective and/or growth promoting effects (58).

Bcl-2 family proteins are key regulatory components of the mitochondrial cell death pathway (9, 10). Some family members are cytoprotective (e.g. Bcl-2, Bcl-xL, Bcl-w, Mcl-1), whereas others promote apoptosis (e.g. Bad, Bak, Bax, Bid, Bim, Bmf). These proteins act at the mitochondria to regulate cytochrome c release. Bcl-2 family proteins act either as heterodimers or as oligomers and the dynamic equilibrium between such complexes appears to determine the predisposition to apoptosis. Translocation of Bax to the mitochondria and oligomerization of Bax and/or Bak promotes permeabilization of the outer mitochondrial membrane and release of cytochrome c and other apoptosis-inducing factors, possibly by forming a pore in the membrane. Heterodimerization with either Bcl-2 or Bcl-xL prevents oligomerization and protects from apoptosis. Other pro-apoptotic proteins, such as Bad, Bim, or Bmf compete for binding to Bcl-2/Bcl-xL causing release of Bax/Bak, which can then form oligomers and induce apoptosis. Thus, the balance between pro- and anti-apoptotic Bcl-2 family proteins influences the rate of apoptosis.

Bcl-2 and Bcl-xL are the principal Bcl-2 family proteins that protect cells from apoptosis. The regulation of the Bcl-x gene appears particularly complex. Initial studies of the mouse Bcl-x gene demonstrated that, like Bcl-2, the Bcl-x gene consisted of three separate exons (11). Exon 1 is untranslated and is separated from the first coding exon, exon 2, by a short facultative intron. Exon 3 codes for the C terminus of Bcl-xL and is separated from exon 2 by a large intron of at least 9 kb. At least four proteins potentially derive from alternatively spliced Bcl-x mRNAs. Exons 1, 2, and 3 are spliced together to produce Bcl-xL. Splicing from an alternative donor site within exon 2 to exon 3 results in a shorter form of the protein (Bcl-xS), which lacks a central region present in Bcl-xL, but the reading frame is maintained and the C terminus is identical (11). In contrast to Bcl-xL, Bcl-xS induces apoptosis. Read-through of the donor site at the end of exon 2 produces Bcl-x{beta} (12), and splicing of exon 2 to a novel exon 4 generates Bcl-x{gamma} (13). Apart from alternative splicing of the coding exons of the Bcl-x gene, there is additional complexity in the regulation of the 5' non-coding region. Grillot et al. (11) reported the presence of at least two principal transcription initiation sites for exon 1 at –655 and –727, in addition to a cluster of initiation sites at the start of exon 2. Subsequently, an alternative first exon upstream of exon 1 (exon 1B) was identified in human lymphoma cells (14). A third study suggested that at least five different promoters (P1–P5) operate in the mouse Bcl-x gene, each of which is associated with a different first exon (exons A–E) (15). This terminology is confusing, since exons A and B correspond, respectively, to exons 2 and 1 identified by Grillot et al. (11), and exon C corresponds to the region identified as exon 1B (14). The different exons of the Bcl-x gene are summarized in Fig. 1. Despite the identification of potential promoters and transcriptional start sites further upstream in the Bcl-x gene (i.e. exons D and E (15)), expression of these exons was not detected in erythroid progenitor cells or differentiating erythroblasts in which Bcl-xL is up-regulated (16), and their significance in a biological system remains to be established.



View larger version (12K):
[in this window]
[in a new window]
 
FIG. 1.
Exon structure of the mouse Bcl-x gene. The exon numbering system has been adapted from the schemes by Grillot et al. (11) and MacCarthy-Morrogh et al. (14), with the system (exons A–E) used by Pecci et al. (15) shown below. Bcl-x primer pairs that were used are also shown (for further details see Table I). bp numbering extends from the first coding ATG. Exons and introns are not shown to scale.

 


View this table:
[in this window]
[in a new window]
 
TABLE I
Primers used for RT-PCR

Nucleotide positions for each primer are shown in parentheses. Different primers were used for analysis of the Bcl-x promoters for mouse (M) and rat (R).

 
A number of Bcl-2 family proteins are expressed in cardiac myocytes including Bcl-2, Bcl-xL, Bad, Bax, and Bid (4, 17, 18). As in other cells, overexpression of Bcl-2 in cardiac myocytes is cytoprotective (1921). H2O2-induced apoptosis in neonatal myocytes is associated with rapid translocation of Bad and Bax to the mitochondria (<5 min), an event which precedes cytochrome c release (4, 17), suggesting that, in the context of oxidative stress, Bad/Bax translocation may be one of the initiating events. Bcl-2 family proteins are therefore key regulators of apoptosis in cardiac myocytes, as in other cells, and the expression of the various family members is likely to influence the rate of myocyte death. In this study, we examined the effects of H2O2 on the expression of four key family members which are readily detected in cardiac myocytes (Bcl-2, Bcl-xL, Bax, and Bad).


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Preparation of Neonatal Rat or Mouse Cardiac Myocytes—Myocytes were dissociated from the ventricles of 1–3-day Sprague-Dawley rat hearts as described previously (22) and plated at a density of 1.4 x 103 cells/mm2 in 35-mm Primaria tissue culture dishes precoated with 1% (w/v) gelatin. Neonatal mouse myocytes were prepared from the ventricles of C57Bl6 mice using essentially the same procedure as for neonatal rat myocytes, and cells were plated at a density of 2.0 x 103 cells/mm2. Myocytes were plated in Dulbecco's modified Eagle's medium/M199 (4:1) containing 5% (v/v) fetal calf serum and 10% (v/v) horse serum (16 h, 37 °C), and then incubated in serum-free medium for 24 h prior to experimentation. Myocytes were exposed to H2O2 (0.02 mM, 0.2 mM, 2 mM) for the times indicated.

Immunoblot Analysis—Myocytes were washed in Ca2+/Mg2+-free Dulbeccos phosphate-buffered saline (Invitrogen), extracted in Buffer A (20 mM glycerophosphate, pH 7.5, 50 mM NaF, 2 µM microcystin LR, 2 mM EDTA, 0.2 mM Na3VO4, 10 mM benzamidine, 200 µM leupeptin, 10 µM trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane, 5 mM dithiothreitol, 300 µM phenylsulfonyl fluoride, 1% (v/v) Triton X-100) and centrifuged (10,000 x g, 5 min). The supernatants were boiled with 0.33-volume sample buffer (0.33 M Tris-HCl, pH 6.8, 10% (w/v) SDS, 13% (v/v) glycerol, 133 mM dithiothreitol, 0.2 mg/ml bromphenol blue). Proteins (15 µg) were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using 15% (w/v) polyacrylamide gels and transferred to nitrocellulose membranes as described previously (23). Blots were incubated in Tris-buffered saline containing 0.05% (v/v) Tween 20 (TBST) and 5% (w/v) nonfat milk powder to block nonspecific binding. Blots were washed (TBST, 3 x 5 min) and incubated with primary antibodies in TBST containing 5% (w/v) bovine serum albumin (16 h, 4 °C). Primary antibodies to Bcl-xL (H-5), Bcl-2 (C-2), or Bax (B-9) were from Santa Cruz Biotechnology Inc. and used at 1/400 dilution; antibodies to total Bad (B36420 [GenBank] ) were from BD Transduction Laboratories and used at 1/1000 dilution. Blots were washed (TBST, 3 x 5 min) and incubated with secondary antibodies conjugated to horse-radish peroxidase diluted in TBST containing 1% (w/v) nonfat milk powder (1 h, 20 °C). Bands were detected by enhanced chemiluminescence (Santa Cruz Biotechnology Inc.) and were quantified by scanning densitometry.

Total RNA Isolation and cDNA Synthesis—Myocytes were homogenized in 0.5 ml of RNAzol B (AMS Biotech) and total RNA prepared according to the manufacturer's instructions. RNA pellets were dissolved in diethyl pyrocarbonate-treated water, and the concentrations were calculated from the A260. First strand cDNA synthesis was performed from total RNA (2 µg) in a reaction mixture containing 500 oligo(dT) and 1 mM dNTP mix. Tubes were heated (65 °C, 5 min). 5 x first-strand buffer, 0.1 M dithiothreitol, recombinant ribonuclease inhibitor (40 units) and Superscript II RNase H reverse transcriptase (200 U) (Invitrogen) were added, and cDNA synthesis was performed (50 min, 42 °C).

Preparation of Genomic DNA—Rat spleen (stored at –80 °C) was powdered under liquid N2, homogenized in Buffer ATL (Qiagen DNeasy tissue DNA extraction kit), and passed through a 21-gauge needle 5–20 times. DNA was extracted according to the manufacturer's instructions, eluted in 100 µl, and the concentration was calculated from the A260.

Ratiometric RT1-PCR Analysis—Ratiometric RT-PCR was performed as previously described, and in our hands, results from this method are comparable with those obtained by quantitative "real-time" PCR (24). Primers were designed for the coding regions of rat Bcl-2, Bad, and Bax and for mouse or rat Bcl-xL coding region. Primers for the Bcl-xL coding region (exon 2) were designed not to detect Bcl-xS. Primers were also designed for each of the potential first exons upstream of exon 2 of the Bcl-x gene and to amplify the region across exons 1 and 2 (Table I and Fig. 1). To avoid confusion, we have used the Grillot/MacCarthy-Morrogh (11, 14) terminology referring to exons D and E of the Pecci et al. study (15) as exons 1C and 1D (Fig. 1). RT-PCR reactions were carried out in a 50-µl volume containing 100 ng of cDNA or 20 ng of genomic DNA template, 100 µM concentration of each primer, 50 mM KCl, 20 mM Tris-HCl (pH 8.4 at 25 °C), 1.5 mM MgCl2, 0.01% (v/v) Tween 20, and a 0.2 mM concentration each of dATP, dCTP, dGTP, dTTP, using 1 unit of Taq polymerase (Invitrogen). The following conditions were used: 95 °C, 3 min followed by 24–31 cycles of denaturation (95 °C, 50 s), annealing (61 °C, 50 s), and extension (72 °C, 50 s). Amplification products were analyzed by ethidium bromide-agarose gel electrophoresis using 2% (w/v) agarose gels and the bands captured under UV illumination. All primer sets generated clean products of the predicted sizes (Table I). Products were analyzed by scanning densitometry and normalized to GAPDH. Results are expressed relative to unstimulated controls.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
H2O2 Promotes Down-regulation of Bcl-2 Family Proteins in Cardiac Myocytes—We examined the effects of different concentrations of H2O2 (2, 0.2, and 0.02 mM) on the expression of four principal Bcl-2 family proteins, which are expressed in cardiac myocytes: Bcl-2, Bcl-xL, Bax, and Bad. 0.2 mM H2O2 results in myocyte death associated with features of apoptosis (4), whereas higher concentrations induce non-apoptotic cell death. 0.02 mM H2O2 is non-toxic, but has effects on gene expression.2 Neonatal rat cardiac myocytes were exposed to H2O2 for up to 24 h, and the levels of Bcl-2, Bcl-xL, Bax, and Bad were compared by immunoblotting. High concentrations of H2O2 (2 mM) induced profound down-regulation of all four proteins (Fig. 2, A–D). Down-regulation of pro-apoptotic Bax and Bad was apparent within 1–2 h (Fig. 2, A and B), whereas down-regulation of anti-apoptotic Bcl-2 and Bcl-xL was not significant before ~4 h (Fig. 2, C and D). The levels of Bax and Bad were also decreased in myocytes exposed to 0.2 mM H2O2 (Fig. 2, E and F), albeit to a lesser extent than in myocytes exposed to 2 mM H2O2 (Fig. 2, A and B). Bcl-2 was down-regulated to a similar degree and over a similar time course in response to both concentrations (Fig. 2, C and G). In contrast, although Bcl-xL protein initially decreased in myocytes exposed to 0.2 mM H2O2 (~70% over 2–4 h), it was re-expressed, and after 24 h the levels of Bcl-xL were similar to those of unstimulated control cells (Fig. 2H). The expression of all four Bcl-2 family proteins did not change in myocytes exposed to 0.02 mM H2O2 (results not shown). These data indicate that, of the four Bcl-2 family proteins, only Bcl-xL is re-expressed following stimulation by oxidative stress at a concentration that promotes apoptosis.



View larger version (28K):
[in this window]
[in a new window]
 
FIG. 2.
H2O2 induces down-regulation of Bax, Bad, Bcl-2, and Bcl-xL in rat cardiac myocytes. Rat neonatal cardiac myocytes were exposed to 2 mM (A–D) or 0.2 mM (E–H) H2O2 for the times indicated. Extracts were immunoblotted for Bax (A and E), Bad (B and F), Bcl-2 (C and G), or Bcl-xL (D and H). Representative blots are shown in the upper panels; densitometric analysis of the data is provided in the lower panels expressed relative to controls. Results are means ± S.E. for 3 (B and D), 4 (G and H), 5 (A, C and F), or 7 (E) independent experiments.

 

H2O2 Induces Bcl-xL mRNA Expression—To determine whether re-expression of Bcl-xL protein in response to 0.2 mM H2O2 reflected an increase in mRNA expression (rather than an effect on protein synthesis or stability) and that this was a selective effect, neonatal rat cardiac myocytes were exposed to 0.2 mM H2O2, and ratiometric RT-PCR analysis of Bcl-xL, Bcl-2, Bax, and Bad was performed. Primers were designed to detect expression of the coding regions of the mRNAs for each gene (Table I). Consistent with the protein data (Fig. 2H), Bcl-xL (exon 2) mRNA was up-regulated from 2 to 4 h, and this was sustained over the 8-h period studied (Fig. 3A). In contrast, there was no change in expression of Bcl-2 or Bax mRNA (Fig. 3, B and C), and Bad was marginally down-regulated at the mRNA level (Fig. 3D). Since more detailed analysis of the regulation of Bcl-x has been performed for the mouse gene than for the rat gene (15), we confirmed that Bcl-xL mRNA was up-regulated in neonatal mouse cardiac myocytes in response to 0.2 mM H2O2.As in rat myocytes, Bcl-xL mRNA expression was increased at 2 and 4 h (Fig. 3F). Thus, 0.2 mM H2O2 increases the expression of Bcl-xL mRNA in cardiac myocytes, and this probably accounts for the selective re-expression of Bcl-xL protein.



View larger version (32K):
[in this window]
[in a new window]
 
FIG. 3.
H2O2 (0.2 mM) promotes selective up-regulation of Bcl-xL mRNA in rat or mouse cardiac myocytes. Rat neonatal cardiac myocytes were exposed to 0.2 mM H2O2 for the times indicated. The expression of Bcl-xL (exon 2) (A), Bcl-2 (B), Bax (C), or Bad (D) mRNA was analyzed by ratiometric RT-PCR. Representative images from a single experiment are shown in the upper panels. The expression of GAPDH in the samples from the same experiment is also shown (E). Densitometric analysis of the data is provided in the lower panels expressed relative to controls. Results are means ± S.E. for 4 (B) or 5 (A, C, and D) independent experiments. F, mouse neonatal cardiac myocytes were exposed to 0.2 mM H2O2 for the times indicated, and the expression of Bcl-xL mRNA was analyzed by ratiometric RT-PCR. A representative image of Bcl-xL (exon 2) expression and the corresponding GAPDH is shown in the upper panel. Densitometric analysis of the data is provided in the lower panel expressed relative to controls. Results are means ± S.E. for three independent experiments.

 

Up-regulation of Bcl-xL mRNA by H2O2 Is Mediated by Selective Promoter Activation—As illustrated in Fig. 1, four putative untranslated first exons have been identified for the mouse Bcl-x gene (15). To avoid confusion we have extended the terminology used by MacCarthy-Morrogh et al. (14) and refer to exons 1 (the original first exon identified by Grillot et al. (11)), 1B, 1C, and 1D (which correlate to exons C, D, and E described by Pecci et al. (15)). Transcripts containing exons 1 and 1B had been previously detected in heart extracts, but whether exons 1C and 1D are also expressed had not been studied. Using specific primers to each of the untranslated exons of the mouse Bcl-x gene for ratiometric RT-PCR analysis, we confirmed that exons 1 and 1B were expressed in adult mouse heart and all other tissues studied (spleen, kidney, liver, and brain) (Fig. 4A). Exon 1C, but not exon 1D, was also detected in all adult mouse tissues (Fig. 4A and results not shown). Bcl-x exons 1, 1B, and 1C were all readily detected in neonatal mouse cardiac myocyte cultures confirming expression in the myocytes themselves. However, although it was not detected in adult hearts, exon 1D was expressed in neonatal cardiac myocytes (Fig. 4B), suggesting that expression of this region is down-regulated during postnatal development of the heart. Since all primers were designed to amplify regions within individual predicted exons, we considered it necessary to confirm that there was no contamination of samples with genomic DNA and primers were designed for RT-PCR to amplify the region across the intron between exons 1 and 2. RT-PCR analysis of cDNA samples resulted in a single product of 433 bp, consistent with splicing of exon 1 to exon 2 generating a single mRNA species (Fig. 4C). This contrasts with a previous study in which differential splicing across this region produced three different mRNAs (15). Amplification of genomic DNA resulted in a product of 615 bp (Fig. 4C) encompassing the intron and confirming that there was no significant contamination of samples with genomic DNA.



View larger version (38K):
[in this window]
[in a new window]
 
FIG. 4.
Expression of Bcl-x non-coding exons 1, 1B, 1C, and 1D in mouse tissues, and cardiac myocytes. RNA was extracted from adult mouse heart, spleen, kidney, liver, and brain (A and B) or from mouse neonatal cardiac myocytes (B and C), or genomic DNA was prepared (A and C). The expression of Bcl-x exons 1, 1B, 1C, and 1D, and the region encompassing the intron between exon 1 and exon 2 was examined by ratiometric RT-PCR analysis using the primers detailed in Table I.

 

To determine which of the untranslated exons are expressed in response to H2O2, neonatal mouse cardiac myocytes were exposed to 0.2 mM H2O2, and the different exons were analyzed by ratiometric RT-PCR. The expression of exon 1 did not change in response H2O2, whereas exons 1B, 1C, and 1D were all significantly increased (Fig. 5A). The sequence for the region 5' to the rat Bcl-x gene has recently become available and comparison of the region encompassing all potential untranslated first exons with the mouse sequence indicates a high degree of conservation from some distance upstream of exon 1D through to the first coding ATG of the Bcl-x gene (see on-line Supplemental Material). Using primers specific for the rat sequence (Table I), we demonstrated that, consistent with the data for mouse myocytes (Fig. 5A), 0.2 mM H2O2 selectively increased the expression of exons 1B, 1C, and 1D in neonatal rat cardiac myocytes with no change in expression of exon 1 (Fig. 5, B and C). These data suggest that oxidative stress results in specific expression of the distal untranslated exons of the Bcl-x gene in cardiac myocytes rather than the most proximal exon 1.



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 5.
H2O2 selectively up-regulates the expression of Bcl-x exons 1B, 1C, and 1D, but not exon 1. Mouse (A) or rat (B and C) neonatal cardiac myocytes were exposed to 0.2 mM H2O2 for the times indicated. RNA was extracted, and the expression of Bcl-x exons 1, 1B, 1C, and 1D was examined by ratiometric RT-PCR analysis using the primers detailed in Table I. Representative images from a single experiment are shown in the upper panels, in addition to the expression of GAPDH in the same samples. Densitometric analysis of the data is provided in the lower panels expressed relative to controls. Results are means ± S.E. for 3 (C), 4 (A), or 5 (B) independent experiments.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Down-regulation of Bcl-2 Family Proteins during Cardiac Myocyte Death—H2O2, as an example of oxidative stress, induces cardiac myocyte death. In response to 2 mM H2O2, which should induce a more necrotic phenotype, all four Bcl-2 family proteins studied were profoundly down-regulated (Fig. 2, A–D). In contrast, in response to 0.2 mM H2O2, which induces apoptosis, although the down-regulation of Bcl-2 was similar to that seen in response to 2 mM H2O2, the effect on Bax and Bad was less pronounced (Fig. 2, EG). Furthermore, although Bcl-xL decreased initially, the protein was re-expressed (Fig. 2H). The effects of the two concentrations on Bcl-2 family proteins are therefore distinct and may be a reflection of the type of cell death. The mechanisms involved in the down-regulation of these Bcl-2 family proteins were not investigated in this study. However, the down-regulation of Bcl-2, Bax, and Bad in response to 0.2 mM H2O2 is likely to be primarily due to increased protein degradation and/or reduced protein synthesis, since the mRNA levels for Bcl-2 and Bax did not change and, although there was a decrease in Bad mRNA, this was relatively modest (Fig. 3, B–D). The initial decline in Bcl-xL protein also probably reflects increased degradation, since Bcl-xL mRNA expression did not change significantly before ~2 h (Fig. 3A). The subsequent increase in Bcl-xL mRNA presumably accounts for the re-expression of Bcl-xL protein from ~ 4–6 h (Fig. 2H). There was some variability in the time at which Bcl-xL protein was re-expressed, which may be due to a conflict between the rate of protein degradation and synthesis of new protein. The significance of Bcl-xL re-expression in response to 0.2 mM H2O2 is not clear. However, this concentration does not induce apoptosis in all myocytes over 24 h (4), and re-expression of Bcl-xL in surviving cells may be a significant component of the survival program.

Regulation of Bcl-xL mRNA Expression in Cardiac Myocytes—Although Bcl-x transcripts have been reported to derive from at least five different promoters (i.e. the region between exons 1 and 2 and regions upstream of exons 1, 1B, 1C, and 1D), only the three most proximal (regions upstream of exons 2, 1, and 1B) were previously shown to be operative in the heart (15). In this study, we demonstrated that exon 1C was expressed in adult mouse heart and neonatal cardiac myocytes, and although it was not detected in adult hearts, exon 1D was expressed in neonatal cardiac myocytes (Fig. 4A). These data suggest that there is developmental regulation of the upstream promoters such that exon 1D is no longer expressed in adult hearts. Our preliminary data suggest that, in neonatal cardiac myocytes, exons 1D and 1C are expressed as a single exon that incorporates the intervening sequence (results not shown). This suggests that during development there is a switch in the transcriptional initiation site that is used. Exons 1C/1D do not appear to be continuous with exon 1B (results not shown). Consistent with this, comparison of the mouse and rat sequences indicates that there is a region of low homology between exon 1C and exon 1B (see on-line Supplemental Material).

Although all four untranslated exons were detected in neonatal cardiac myocytes, only the expression of exons 1B, 1C, and 1D was significantly increased by 0.2 mM H2O2, with no increase in exon 1 (Fig. 5). The reasons for multiple promoter usage and differential expression of untranslated exons are unclear, although previous studies suggest that the promoter may influence the isoform of Bcl-x which is produced (15). In cardiac myocytes, Bcl-xL (Fig. 2) and Bcl-xS (results not shown) were up-regulated concomitantly, and it is possible that, for example, exon 1B may preferentially induce Bcl-xL whereas exons 1C/1D may induce Bcl-xS. However, there is minimal evidence in support of such a scenario. Alternatively, switching of non-coding exons to produce different 5'-untranslated regions may influence the mode and rate of translation. In cardiac myocytes, H2O2 (>0.1 mM) suppresses global protein synthesis by ~95% over at least 4 h, probably because of repression of cap-dependent initiation of translation (25). However, a small group of proteins continues to be synthesized, including p21CIP1/WAF1 (26), presumably through cap-independent mechanisms. An increasing number of eukaryotic mRNAs have been identified which contain internal ribosome entry sites required for cap-independent protein synthesis (see ifr31w3.toulouse.inserm.fr/IRESdatabase), and many of these are associated with apoptosis (27). In the case of insulin-like growth factor 2, mRNAs are produced with three different 5'-untranslated regions, only one of which confers cap-independent protein synthesis (28). The specific up-regulation of exons 1B, 1C, and 1D, but not exon 1, by H2O2 in cardiac myocytes may therefore be required for translation to occur in the context of global inhibition of protein synthesis. Most studies so far have focused on the regulation of expression of Bcl-xL from the promoter regions upstream of exons 1 and 2, and binding sites for a number of transcription factors have been identified in this region (11). It is now clear that further analysis of sequences upstream from exons 1B, 1C, and 1D is required to identify the regions that are responsive to H2O2 and establish which transcription factors are involved.

It is of note that the homology between rat, mouse and human Bcl-x gene is extremely high across the region encompassing exons 1B through to exon 3. However, although the homology between the rat and mouse sequences across exons 1C and 1D is high (see on-line Supplemental Material), we have had problems aligning this region with the human sequence (42% identity at best). It is possible exons 1C and 1D represent a different gene from Bcl-x, but the homology between rat and mouse extends almost continuously from some distance 5' to exon 1D through the first coding ATG of Bcl-x, and the regulation of exons 1C and 1D in response to H2O2 is similar to that of exons 1B and Bcl-xL exon 2. Furthermore, the homology between the rat and mouse sequences is lost abruptly some distance 5' to exon 1D (see on-line Supplemental Material), suggesting that this may be the extreme 5' end of the gene. The reasons for the lack of homology with the human sequence are not clear. If exons 1C and 1D are part of another gene, it is possible that this gene is elsewhere on the human genome, but we have been unable to find any human sequences with significant homology to the rat/mouse sequences. It seems more probable that evolutionary constraints on the primary sequence were not high. Motifs for internal ribosome entry sites are not conserved at the primary sequence level, and it is the secondary structure that appears to be of prime importance (29). If the upstream region of the Bcl-x gene produces a mRNA capable of promoting cap-independent translation, the constraints would therefore be expected to occur at the level of secondary structure rather than primary sequence. Further analysis is required to determine whether the upstream region is relevant to expression of human Bcl-x gene products and if this region does indeed promote translation through cap-independent mechanisms.


    FOOTNOTES
 
* This work was supported by grants from the British Heart Foundation, the Medical Research Council, the Wellcome Trust, and the Royal Brompton and Harefield NHS Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

The on-line version of this article (available at http://www.jbc.org) contains supplemental data and a supplemental figure. Back

{ddagger} To whom correspondence should be addressed: NHLI Division (Cardiac Medicine Section), Faculty of Medicine, Imperial College London, Flowers Bldg., Armstrong Rd., London SW7 2AZ, UK. Tel.: 44-20-7594-3009; Fax: 44-20-7594-3419; E-mail: a.clerk{at}imperial.ac.uk.

1 The abbreviations used are: RT, reverse transcriptase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Back

2 T. J. Kemp and A. Clerk, unpublished data. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Vanden Hoek, T. L., Li, C., Shao, Z., Schumacker, P. T., and Becker, L. B. (1997) J. Mol. Cell. Cardiol. 29, 2571–2583[CrossRef][Medline] [Order article via Infotrieve]
  2. Becker, L. B., Vanden Hoek, T. L., Shao, S. H., Li, C. Q., and Schumacker, P. T. (1999) Am. J. Physiol. 277, H2240–H2246[Medline] [Order article via Infotrieve]
  3. Ferrari, R., Agnoletti, L., Comini, L., Gaia, G., Bachetti, T., Cargnoni, A., Ceconi, C., Curello, S., and Visioli, O. (1998) Eur. Heart J. 19, Suppl. B, B2–B11[Medline] [Order article via Infotrieve]
  4. Cook, S. A., Sugden, P. H., and Clerk, A. (1999) Circ. Res. 85, 940–949[Abstract/Free Full Text]
  5. Ytrehus, K., Walsh, R. S., Richards, S. C., and Downey, J. M. (1995) Cardiovasc. Res. 30, 1033–1037[CrossRef][Medline] [Order article via Infotrieve]
  6. Valen, G., Starkopf, J., Takeshima, S., Kullisaar, T., Vihalemm, T., Kengsepp, A. T., Lowbeer, C., Vaage, J., and Zilmer, M. (1998) Free Radic. Res. 29, 235–245[Medline] [Order article via Infotrieve]
  7. Siwik, D. A., Tzortzis, J. D., Pimental, D. R., Chang, D. L., Pagano, P. J., Singh, K., Dawyer, D. B., and Colucci, W. S. (1999) Circ. Res. 85, 147–153[Abstract/Free Full Text]
  8. Chen, Q. M., Tu, V. C., Wu, Y., and Bahl, J. J. (2000) Arch. Biochem. Biophys. 373, 242–248[CrossRef][Medline] [Order article via Infotrieve]
  9. Adams, J. A., and Cory, S. (2001) Trends Biochem. Sci. 21, 61–66[CrossRef]
  10. Antonsson, B. (2001) Cell Tissue Res. 306, 347–361[CrossRef][Medline] [Order article via Infotrieve]
  11. Grillot, D. A. M., Gonzalez-Garcia, M., Ekhterae, D., Duan, L., Inohara, N., Ohta, S., Seldin, M. F., and Nunez, G. (1997) J. Immunol. 158, 4750–4757[Abstract]
  12. Shiraiwa, N., Inohara, N., Okad, S., Yuzaki, M., Shoji, S., and Ohta, S. (1996) J. Biol. Chem. 271, 13258–13265[Abstract/Free Full Text]
  13. Yang, X.-F., Weber, G. F., and Cantor, H. (1997) Immunity 7, 629–639[Medline] [Order article via Infotrieve]
  14. MacCarthy-Morrogh, L., Wood, L., Brimmell, M., Johnson, P. W. M., and Packham, G. (2000) Oncogene 19, 5534–5538[CrossRef][Medline] [Order article via Infotrieve]
  15. Pecci, A., Viegas, L. R., Baranao, J. L., and Beato, M. (2001) J. Biol. Chem. 276, 21062–21069[Abstract/Free Full Text]
  16. Tian, C., Gregoli, P., and Bondurant, M. (2003) Blood 101, 2235–2242[Abstract/Free Full Text]
  17. von Harsdorf, R., Li, P.-F., and Dietz, R. (1999) Circulation 99, 2934–2941[Abstract/Free Full Text]
  18. Chen, M., He, H., Zhan, S., Krajewski, S., Reed, J. C., and Gottlieb, R. A. (2001) J. Biol. Chem. 276, 30724–30728[Abstract/Free Full Text]
  19. Kirshenbaum, L. A., and de Moissac, D. (1997) Circulation 96, 1580–1585[Abstract/Free Full Text]
  20. Kang, P. M., Haunstetter, A., Aoki, H., Usheva, A., and Izumo, S. (2000) Circ. Res. 87, 118–125[Abstract/Free Full Text]
  21. Chen, Z., Chua, C. C., Ho, Y. S., Hamdy, R. C., and Chua, B. H. (2001) Am. J. Physiol. 280, H2313–H2320
  22. Bogoyevitch, M. A., Clerk, A., and Sugden, P. H. (1995) Biochem. J. 309, 437–443[Medline] [Order article via Infotrieve]
  23. Clerk, A., Bogoyevitch, M. A., Fuller, S. J., Lazou, A., Parker, P. J., and Sugden, P. H. (1995) Am. J. Physiol. 269, H1087–H1097[Medline] [Order article via Infotrieve]
  24. Clerk, A., Kemp, T. J., Harrison, J. G., Mullen, A. J., Barton, P. J., and Sugden, P. H. (2002) Biochem. J. 368, 101–110[CrossRef][Medline] [Order article via Infotrieve]
  25. Pham, F. H., Sugden, P. H., and Clerk, A. (2000) Circ. Res. 86, 1252–1258[Abstract/Free Full Text]
  26. Pham, F. H., Cole, S. M., and Clerk, A. (2001) Adv. Enzyme Regul. 41, 73–86[CrossRef][Medline] [Order article via Infotrieve]
  27. Holcik, M., Sonenberg, N., and Korneluk, R. G. (2000) Trends Genet. 16, 469–473[CrossRef][Medline] [Order article via Infotrieve]
  28. Pedersen, S. K., Christiansen, J., Hansen, T. O., Larsen, M. R., and Nielsen, F. C. (2002) Biochem. J. 363, 37–44[CrossRef][Medline] [Order article via Infotrieve]
  29. Martinez-Salas, E., Ramos, R., Lafuente, E., and Lopez deq Uinto, S. (2001) J. Gen. Virol. 82, 973–984[Free Full Text]